View Future GrowthFacephi Biometria 過去の業績過去 基準チェック /26Facephi Biometriaの収益は年間平均-35.1%の割合で減少していますが、 Software業界の収益は年間 増加しています。収益は年間12.8% 24.1%割合で 増加しています。 Facephi Biometriaの自己資本利益率は1.5%であり、純利益率は0.8%です。主要情報-35.11%収益成長率-31.62%EPS成長率Software 業界の成長-29.40%収益成長率24.13%株主資本利益率1.46%ネット・マージン0.78%前回の決算情報31 Dec 2025最近の業績更新お知らせ • Apr 14Facephi Biometria, S.A. to Report Fiscal Year 2025 Results on Apr 29, 2026Facephi Biometria, S.A. announced that they will report fiscal year 2025 results at 5:30 PM, Romance Standard Time on Apr 29, 2026お知らせ • Oct 07Facephi Biometria, S.A. to Report First Half, 2025 Results on Oct 30, 2025Facephi Biometria, S.A. announced that they will report first half, 2025 results on Oct 30, 2025Reported Earnings • May 02Full year 2024 earnings releasedFull year 2024 results: Revenue: €33.5m (up 14% from FY 2023). Net loss: €8.88m (loss widened 106% from FY 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Software industry in Europe.Reported Earnings • Oct 24First half 2024 earnings releasedFirst half 2024 results: Revenue: €14.1m (up 19% from 1H 2023). Net loss: €6.29m (loss widened 34% from 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Software industry in Europe.Reported Earnings • Nov 10First half 2022 earnings releasedFirst half 2022 results: Revenue: €9.72m (up 98% from 1H 2021). Net loss: €1.07m (loss narrowed 37% from 1H 2021). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 9.1% growth forecast for the Software industry in Europe.Reported Earnings • May 01Full year 2021 earnings: Revenues miss analyst expectationsFull year 2021 results: Revenue: €15.3m (up 89% from FY 2020). Net loss: €553.9k (loss narrowed 67% from FY 2020). Revenue missed analyst estimates by 25%.すべての更新を表示Recent updatesお知らせ • May 05Facephi Biometria, S.A. Provides Earnings Guidance for 2026Facephi Biometria, S.A. provided earnings guidance for 2026. The company reiterated revenue EUR 46.2 million (+28.4%).お知らせ • Apr 14Facephi Biometria, S.A. to Report Fiscal Year 2025 Results on Apr 29, 2026Facephi Biometria, S.A. announced that they will report fiscal year 2025 results at 5:30 PM, Romance Standard Time on Apr 29, 2026New Risk • Nov 05New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €7.9m Forecast net loss in 2 years: €1.6m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (6.9% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€1.6m net loss in 2 years). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€73.2m market cap, or US$84.1m).お知らせ • Nov 01Facephi Biometria, S.A. Provides Earnings Guidance for the Fiscal Years 2025 and 2026Facephi Biometria, S.A. provided earnings guidance for the fiscal years 2025 and 2026. For the year 2025, the company expects net revenue of €36.4 million. For the year 2026, the company expects net revenue of €46.2 million.分析記事 • Oct 17A Piece Of The Puzzle Missing From Facephi Biometria, S.A.'s (BME:FACE) Share PriceThere wouldn't be many who think Facephi Biometria, S.A.'s ( BME:FACE ) price-to-sales (or "P/S") ratio of 1.9x is...お知らせ • Oct 07Facephi Biometria, S.A. to Report First Half, 2025 Results on Oct 30, 2025Facephi Biometria, S.A. announced that they will report first half, 2025 results on Oct 30, 2025New Risk • Sep 10New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€68.7m market cap, or US$80.4m).New Risk • Aug 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Spanish stocks, typically moving 4.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (4.3% average weekly change). Market cap is less than US$100m (€64.2m market cap, or US$74.5m).お知らせ • Aug 07Facephi Launches Advanced Injection Defense Against Deepfakes and AI-Powered Injection AttacksFacephi Biometria, SA has launched Advanced Injection Defense -- a powerful new add-on to its Behavioral Biometrics Solution that brings enhanced protection against deepfakes, spoofing, and manipulated digital content. As the threat landscape evolves, tools capable of creating high-precision fake images and videos are being increasingly used to compromise digital identity systems. Advanced Injection Defense directly addresses this challenge by combining artificial intelligence, forensic image analysis, and real-time capture validation to detect and block even the most convincing injection attacks. This new feature protects against: Injection of pre-recorded or manipulated media; Device emulation and screen replay attacks; Tampering of capture channels and data flows. By analyzing both the image content and the context of capture, Advanced Injection Defense flags anomalies such as simulation, substitution, or manipulation attempts. It enables organizations to verify digital identities with greater certainty and precision. Now available as an add-on to Facephi's Behavioral Biometrics suite, Advanced Injection Defense can be integrated into both new customer onboarding and ongoing authentication processes. It meets rigorous global compliance requirements and is suited for high-risk sectors including: Banking and Financial Services; Healthcare and Insurance; Telecommunications; Government and Public Administration.New Risk • Jun 17New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -€4.5m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-€4.5m free cash flow). Minor Risks Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€63.4m market cap, or US$72.9m).お知らせ • May 19Facephi Biometria, S.A., Annual General Meeting, Jun 16, 2025Facephi Biometria, S.A., Annual General Meeting, Jun 16, 2025. Location: avenida perfecto palacio de la fuente 6, edificio panoramis, alicante., SpainReported Earnings • May 02Full year 2024 earnings releasedFull year 2024 results: Revenue: €33.5m (up 14% from FY 2023). Net loss: €8.88m (loss widened 106% from FY 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Software industry in Europe.New Risk • Apr 15New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.9% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€60.9m market cap, or US$68.8m).New Risk • Mar 19New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Spanish stocks, typically moving 6.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€9.3m free cash flow). Share price has been highly volatile over the past 3 months (6.4% average weekly change). Minor Risk Market cap is less than US$100m (€50.4m market cap, or US$54.9m).お知らせ • Mar 13Facephi Accelerates the Digitalization of the Air Travel with Verified Identity and its KYP (Know Your Passenger) Solution at the IATA World Data SymposiumFacephi has reinforced its commitment to transforming the aviation sector at the IATA World Data Symposium. At this key industry event, the company showcased several solutions aimed at enabling a fully digital air travel experience, aligning with IATA's One ID initiative, which seeks to eliminate airport frictionless through verifiable credentials and facial biometrics. Currently, passengers must verify their identity at multiple checkpoints throughout a single journey, leading to delays and increased congestion at airports. To address this challenge, Facephi has developed technology that enables identity validation before arriving at the airport, reducing wait times and ensuring a seamless and secure travel experience. This innovation has already been successfully tested in collaboration with IATA through a proof of concept conducted last November. Complementing other solutions that have proven to reduce processing times by 40%, Facephi advocates for a decentralized model that enhances security and privacy. By leveraging verifiable credentials (VCs) and secure digital wallets, passengers have full control over when and how they share their personal information, ensuring compliance with global data protection regulations. Facephi's approach integrates advanced biometric verification with strong customer authentication (SCA) technologies, enabling fast, contactless identification at every checkpoint. From passport scanning to generating a Type 1 Digital Travel Credential (DTC) and creating verifiable credentials, travelers can securely store and manage their digital identity, streamlining check-in, security checks, and boarding processes. Setting new standards for interoperability: By aligning with IATA's core principles, Facephi ensures interoperability standards between airlines, airports, and government authorities. With the creation of VCs at a Level of Assurance High (Immigration Level) that can be used by government entities, Facephi reaffirms its leadership in aviation digitalization. The company's strong commitment to this industry translates into innovative solutions that not only optimize operational efficiency at airports but also empower passengers by giving them greater control over their digital identity.分析記事 • Mar 05An Intrinsic Calculation For Facephi Biometria, S.A. (BME:FACE) Suggests It's 42% UndervaluedKey Insights Using the 2 Stage Free Cash Flow to Equity, Facephi Biometria fair value estimate is €4.10 Facephi...お知らせ • Mar 02Facephi Biometria, SA Unveils Know Your Passenger at IATA’s World Data SymposiumFacephi Biometria, SA is showcasing its Know Your Passenger (KYP) solution to revolutionize air travel at IATA's World Data Symposium (WDS) in Dublin on February 26th and 27th, 2025. It follows the success of Facephi's digital travel test, conducted last November, in collaboration with the International Air Transport Association (IATA) and other companies, that enabled travelers to complete a round trip between Hong Kong and Narita (Tokyo) without the need for physical credentials, marking a pivotal step toward the future of 100% digital air travel. At IATA's World Data Sym Symposium, Facephi will showcase how KYP is setting new standards in seamless passenger experiences. This solution enhances security, while streamlining travel, eliminating the need for physical documents, and offering a faster, contactless, and highly efficient journey. Key Features of KYP: Seamless digital onboarding: Verified identity before arriving at the airport. Experience adapted to each passenger. The passenger controls how and when to share their data. Phishing-resistant authentication: A secure, passwordless, and friction-free experience with Strong Customer Authentication (SCA). Compliance with global standards: Meeting eIDAS, ICAO, and other regulatory requirements.分析記事 • Jan 21A Piece Of The Puzzle Missing From Facephi Biometria, S.A.'s (BME:FACE) 26% Share Price ClimbFacephi Biometria, S.A. ( BME:FACE ) shares have continued their recent momentum with a 26% gain in the last month...Reported Earnings • Oct 24First half 2024 earnings releasedFirst half 2024 results: Revenue: €14.1m (up 19% from 1H 2023). Net loss: €6.29m (loss widened 34% from 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Software industry in Europe.New Risk • Sep 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Spanish stocks, typically moving 5.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (5.2% average weekly change). Earnings have declined by 51% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (25% increase in shares outstanding). Market cap is less than US$100m (€36.8m market cap, or US$40.7m).New Risk • Jun 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Spanish stocks, typically moving 4.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 51% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (4.6% average weekly change). Shareholders have been diluted in the past year (22% increase in shares outstanding). Market cap is less than US$100m (€42.9m market cap, or US$46.2m).お知らせ • May 31Facephi Biometria, S.A., Annual General Meeting, Jun 28, 2024Facephi Biometria, S.A., Annual General Meeting, Jun 28, 2024. Location: avenida perfecto palacio de la fuente 6, edificiopanoramis, alicante., SpainNew Risk • May 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 39% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (22% increase in shares outstanding). Market cap is less than US$100m (€44.1m market cap, or US$48.0m).お知らせ • Mar 25Facephi Biometria, S.A. announced that it expects to receive funding from Hancom Inc.Facephi Biometria, S.A. announced that it has entered into an investment agreement with returning investor Hancom Inc. to issue common shares on March 25, 2024.分析記事 • Dec 28Cautious Investors Not Rewarding Facephi Biometria, S.A.'s (BME:FACE) Performance CompletelyThere wouldn't be many who think Facephi Biometria, S.A.'s ( BME:FACE ) price-to-sales (or "P/S") ratio of 1.6x is...New Risk • Nov 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.9% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Large one-off items impacting financial results. Shareholders have been diluted in the past year (14% increase in shares outstanding). Market cap is less than US$100m (€47.5m market cap, or US$51.7m).分析記事 • Oct 04At €1.81, Is Facephi Biometria, S.A. (BME:FACE) Worth Looking At Closely?While Facephi Biometria, S.A. ( BME:FACE ) might not be the most widely known stock at the moment, it saw significant...Valuation Update With 7 Day Price Move • Oct 03Investor sentiment deteriorates as stock falls 32%After last week's 32% share price decline to €1.81, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 25x in the Software industry in Europe. Total loss to shareholders of 68% over the past three years.分析記事 • Dec 23Investors Will Want Facephi Biometria's (BME:FACE) Growth In ROCE To PersistIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...Board Change • Nov 16Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 6 new directors. 3 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Vice President of the Board Fernando Orteso De Travesedo is the most experienced director on the board, commencing their role in 2015. Independent Director Pablo Boranat was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • Nov 10First half 2022 earnings releasedFirst half 2022 results: Revenue: €9.72m (up 98% from 1H 2021). Net loss: €1.07m (loss narrowed 37% from 1H 2021). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 9.1% growth forecast for the Software industry in Europe.分析記事 • May 20Would Facephi Biometria (BME:FACE) Be Better Off With Less Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Reported Earnings • May 01Full year 2021 earnings: Revenues miss analyst expectationsFull year 2021 results: Revenue: €15.3m (up 89% from FY 2020). Net loss: €553.9k (loss narrowed 67% from FY 2020). Revenue missed analyst estimates by 25%.Board Change • Apr 27Less than half of directors are independentThere are 7 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 7 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Fernando Orteso De Travesedo is the most experienced director on the board, commencing their role in 2015. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.分析記事 • Jan 01What Does Facephi Biometria, S.A.'s (BME:FACE) Share Price Indicate?Facephi Biometria, S.A. ( BME:FACE ), might not be a large cap stock, but it saw significant share price movement...Reported Earnings • May 24Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: €8.13m (down 7.5% from FY 2019). Net loss: €1.68m (down 231% from profit in FY 2019).分析記事 • Feb 14When Should You Buy Facephi Biometria, S.A. (BME:FACE)?Facephi Biometria, S.A. ( BME:FACE ), might not be a large cap stock, but it received a lot of attention from a...Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to €3.90, the stock is trading at a trailing P/E ratio of 52x, down from the previous P/E ratio of 64.7x. This compares to an average P/E of 40x in the Software industry in Europe. Total returns to shareholders over the past three years are 282%.Is New 90 Day High Low • Feb 01New 90-day low: €3.90The company is down 31% from its price of €5.68 on 03 November 2020. The Spanish market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 14% over the same period.分析記事 • Jan 25We Wouldn't Rely On Facephi Biometria's (BME:FACE) Statutory Earnings As A GuideBroadly speaking, profitable businesses are less risky than unprofitable ones. Having said that, sometimes statutory...Is New 90 Day High Low • Jan 15New 90-day low: €4.95The company is down 20% from its price of €6.20 on 16 October 2020. The Spanish market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 9.0% over the same period.Is New 90 Day High Low • Dec 30New 90-day low: €5.04The company is down 13% from its price of €5.80 on 01 October 2020. The Spanish market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 7.0% over the same period.分析記事 • Dec 30The Facephi Biometria (BME:FACE) Share Price Is Up 979% And Shareholders Are DelightedWhile Facephi Biometria, S.A. ( BME:FACE ) shareholders are probably generally happy, the stock hasn't had particularly...Is New 90 Day High Low • Dec 10New 90-day low: €5.38The company is down 13% from its price of €6.18 on 10 September 2020. The Spanish market is up 13% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Software industry, which is down 14% over the same period.Is New 90 Day High Low • Nov 02New 90-day low: €5.44The company is down 6.0% from its price of €5.80 on 04 August 2020. The Spanish market is also down 6.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Software industry, which is down 20% over the same period.収支内訳Facephi Biometria の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BME:FACE 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 2541025030 Sep 2537-425030 Jun 2534-820031 Mar 2534-820031 Dec 2433-924030 Sep 2432-722030 Jun 2432-619031 Mar 2430-518031 Dec 2329-417030 Sep 2329-319030 Jun 2328-321031 Mar 2327-117031 Dec 2226113030 Sep 2223111030 Jun 2220010031 Mar 221809031 Dec 2115-18030 Sep 2113-26030 Jun 2110-35031 Mar 219-24031 Dec 208-24030 Sep 20904030 Jun 201014031 Mar 201013031 Dec 19913030 Sep 19713030 Jun 19512031 Mar 19512031 Dec 18512030 Sep 18412030 Jun 18402031 Mar 18302031 Dec 17302030 Sep 17202030 Jun 171-12031 Mar 172-11031 Dec 16201030 Sep 16202030 Jun 16201031 Mar 16101031 Dec 151-11030 Sep 151-10030 Jun 150-100質の高い収益: FACEには€316.2K } という大きな 一回限りの 損失があり、過去 12 か月の財務実績が31st December, 2025に影響を及ぼしています。利益率の向上: FACE過去に利益を上げました。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: FACE過去 5 年間で収益を上げており、収益は年間-35.1%増加しています。成長の加速: FACEは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。収益対業界: FACE昨年収益を上げたため、昨年の収益成長をSoftware業界 ( 10.3% ) と比較することは困難です。株主資本利益率高いROE: FACEの 自己資本利益率 ( 1.5% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YSoftware 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 12:17終値2026/05/27 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Facephi Biometria, S.A. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Ignacio Domínguez RuizJB Capital MarketsDavid López SánchezJB Capital MarketsAlfredo Echevarria OteguiLighthouse-IEAF Servicios de Analisis
お知らせ • Apr 14Facephi Biometria, S.A. to Report Fiscal Year 2025 Results on Apr 29, 2026Facephi Biometria, S.A. announced that they will report fiscal year 2025 results at 5:30 PM, Romance Standard Time on Apr 29, 2026
お知らせ • Oct 07Facephi Biometria, S.A. to Report First Half, 2025 Results on Oct 30, 2025Facephi Biometria, S.A. announced that they will report first half, 2025 results on Oct 30, 2025
Reported Earnings • May 02Full year 2024 earnings releasedFull year 2024 results: Revenue: €33.5m (up 14% from FY 2023). Net loss: €8.88m (loss widened 106% from FY 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Software industry in Europe.
Reported Earnings • Oct 24First half 2024 earnings releasedFirst half 2024 results: Revenue: €14.1m (up 19% from 1H 2023). Net loss: €6.29m (loss widened 34% from 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Software industry in Europe.
Reported Earnings • Nov 10First half 2022 earnings releasedFirst half 2022 results: Revenue: €9.72m (up 98% from 1H 2021). Net loss: €1.07m (loss narrowed 37% from 1H 2021). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 9.1% growth forecast for the Software industry in Europe.
Reported Earnings • May 01Full year 2021 earnings: Revenues miss analyst expectationsFull year 2021 results: Revenue: €15.3m (up 89% from FY 2020). Net loss: €553.9k (loss narrowed 67% from FY 2020). Revenue missed analyst estimates by 25%.
お知らせ • May 05Facephi Biometria, S.A. Provides Earnings Guidance for 2026Facephi Biometria, S.A. provided earnings guidance for 2026. The company reiterated revenue EUR 46.2 million (+28.4%).
お知らせ • Apr 14Facephi Biometria, S.A. to Report Fiscal Year 2025 Results on Apr 29, 2026Facephi Biometria, S.A. announced that they will report fiscal year 2025 results at 5:30 PM, Romance Standard Time on Apr 29, 2026
New Risk • Nov 05New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: €7.9m Forecast net loss in 2 years: €1.6m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (6.9% average weekly change). Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (€1.6m net loss in 2 years). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€73.2m market cap, or US$84.1m).
お知らせ • Nov 01Facephi Biometria, S.A. Provides Earnings Guidance for the Fiscal Years 2025 and 2026Facephi Biometria, S.A. provided earnings guidance for the fiscal years 2025 and 2026. For the year 2025, the company expects net revenue of €36.4 million. For the year 2026, the company expects net revenue of €46.2 million.
分析記事 • Oct 17A Piece Of The Puzzle Missing From Facephi Biometria, S.A.'s (BME:FACE) Share PriceThere wouldn't be many who think Facephi Biometria, S.A.'s ( BME:FACE ) price-to-sales (or "P/S") ratio of 1.9x is...
お知らせ • Oct 07Facephi Biometria, S.A. to Report First Half, 2025 Results on Oct 30, 2025Facephi Biometria, S.A. announced that they will report first half, 2025 results on Oct 30, 2025
New Risk • Sep 10New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€68.7m market cap, or US$80.4m).
New Risk • Aug 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Spanish stocks, typically moving 4.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (4.3% average weekly change). Market cap is less than US$100m (€64.2m market cap, or US$74.5m).
お知らせ • Aug 07Facephi Launches Advanced Injection Defense Against Deepfakes and AI-Powered Injection AttacksFacephi Biometria, SA has launched Advanced Injection Defense -- a powerful new add-on to its Behavioral Biometrics Solution that brings enhanced protection against deepfakes, spoofing, and manipulated digital content. As the threat landscape evolves, tools capable of creating high-precision fake images and videos are being increasingly used to compromise digital identity systems. Advanced Injection Defense directly addresses this challenge by combining artificial intelligence, forensic image analysis, and real-time capture validation to detect and block even the most convincing injection attacks. This new feature protects against: Injection of pre-recorded or manipulated media; Device emulation and screen replay attacks; Tampering of capture channels and data flows. By analyzing both the image content and the context of capture, Advanced Injection Defense flags anomalies such as simulation, substitution, or manipulation attempts. It enables organizations to verify digital identities with greater certainty and precision. Now available as an add-on to Facephi's Behavioral Biometrics suite, Advanced Injection Defense can be integrated into both new customer onboarding and ongoing authentication processes. It meets rigorous global compliance requirements and is suited for high-risk sectors including: Banking and Financial Services; Healthcare and Insurance; Telecommunications; Government and Public Administration.
New Risk • Jun 17New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -€4.5m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-€4.5m free cash flow). Minor Risks Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€63.4m market cap, or US$72.9m).
お知らせ • May 19Facephi Biometria, S.A., Annual General Meeting, Jun 16, 2025Facephi Biometria, S.A., Annual General Meeting, Jun 16, 2025. Location: avenida perfecto palacio de la fuente 6, edificio panoramis, alicante., Spain
Reported Earnings • May 02Full year 2024 earnings releasedFull year 2024 results: Revenue: €33.5m (up 14% from FY 2023). Net loss: €8.88m (loss widened 106% from FY 2023). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Software industry in Europe.
New Risk • Apr 15New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 18% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.9% average weekly change). Shareholders have been diluted in the past year (18% increase in shares outstanding). Market cap is less than US$100m (€60.9m market cap, or US$68.8m).
New Risk • Mar 19New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Spanish stocks, typically moving 6.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€9.3m free cash flow). Share price has been highly volatile over the past 3 months (6.4% average weekly change). Minor Risk Market cap is less than US$100m (€50.4m market cap, or US$54.9m).
お知らせ • Mar 13Facephi Accelerates the Digitalization of the Air Travel with Verified Identity and its KYP (Know Your Passenger) Solution at the IATA World Data SymposiumFacephi has reinforced its commitment to transforming the aviation sector at the IATA World Data Symposium. At this key industry event, the company showcased several solutions aimed at enabling a fully digital air travel experience, aligning with IATA's One ID initiative, which seeks to eliminate airport frictionless through verifiable credentials and facial biometrics. Currently, passengers must verify their identity at multiple checkpoints throughout a single journey, leading to delays and increased congestion at airports. To address this challenge, Facephi has developed technology that enables identity validation before arriving at the airport, reducing wait times and ensuring a seamless and secure travel experience. This innovation has already been successfully tested in collaboration with IATA through a proof of concept conducted last November. Complementing other solutions that have proven to reduce processing times by 40%, Facephi advocates for a decentralized model that enhances security and privacy. By leveraging verifiable credentials (VCs) and secure digital wallets, passengers have full control over when and how they share their personal information, ensuring compliance with global data protection regulations. Facephi's approach integrates advanced biometric verification with strong customer authentication (SCA) technologies, enabling fast, contactless identification at every checkpoint. From passport scanning to generating a Type 1 Digital Travel Credential (DTC) and creating verifiable credentials, travelers can securely store and manage their digital identity, streamlining check-in, security checks, and boarding processes. Setting new standards for interoperability: By aligning with IATA's core principles, Facephi ensures interoperability standards between airlines, airports, and government authorities. With the creation of VCs at a Level of Assurance High (Immigration Level) that can be used by government entities, Facephi reaffirms its leadership in aviation digitalization. The company's strong commitment to this industry translates into innovative solutions that not only optimize operational efficiency at airports but also empower passengers by giving them greater control over their digital identity.
分析記事 • Mar 05An Intrinsic Calculation For Facephi Biometria, S.A. (BME:FACE) Suggests It's 42% UndervaluedKey Insights Using the 2 Stage Free Cash Flow to Equity, Facephi Biometria fair value estimate is €4.10 Facephi...
お知らせ • Mar 02Facephi Biometria, SA Unveils Know Your Passenger at IATA’s World Data SymposiumFacephi Biometria, SA is showcasing its Know Your Passenger (KYP) solution to revolutionize air travel at IATA's World Data Symposium (WDS) in Dublin on February 26th and 27th, 2025. It follows the success of Facephi's digital travel test, conducted last November, in collaboration with the International Air Transport Association (IATA) and other companies, that enabled travelers to complete a round trip between Hong Kong and Narita (Tokyo) without the need for physical credentials, marking a pivotal step toward the future of 100% digital air travel. At IATA's World Data Sym Symposium, Facephi will showcase how KYP is setting new standards in seamless passenger experiences. This solution enhances security, while streamlining travel, eliminating the need for physical documents, and offering a faster, contactless, and highly efficient journey. Key Features of KYP: Seamless digital onboarding: Verified identity before arriving at the airport. Experience adapted to each passenger. The passenger controls how and when to share their data. Phishing-resistant authentication: A secure, passwordless, and friction-free experience with Strong Customer Authentication (SCA). Compliance with global standards: Meeting eIDAS, ICAO, and other regulatory requirements.
分析記事 • Jan 21A Piece Of The Puzzle Missing From Facephi Biometria, S.A.'s (BME:FACE) 26% Share Price ClimbFacephi Biometria, S.A. ( BME:FACE ) shares have continued their recent momentum with a 26% gain in the last month...
Reported Earnings • Oct 24First half 2024 earnings releasedFirst half 2024 results: Revenue: €14.1m (up 19% from 1H 2023). Net loss: €6.29m (loss widened 34% from 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Software industry in Europe.
New Risk • Sep 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Spanish stocks, typically moving 5.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (5.2% average weekly change). Earnings have declined by 51% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (25% increase in shares outstanding). Market cap is less than US$100m (€36.8m market cap, or US$40.7m).
New Risk • Jun 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Spanish stocks, typically moving 4.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 51% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (4.6% average weekly change). Shareholders have been diluted in the past year (22% increase in shares outstanding). Market cap is less than US$100m (€42.9m market cap, or US$46.2m).
お知らせ • May 31Facephi Biometria, S.A., Annual General Meeting, Jun 28, 2024Facephi Biometria, S.A., Annual General Meeting, Jun 28, 2024. Location: avenida perfecto palacio de la fuente 6, edificiopanoramis, alicante., Spain
New Risk • May 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 39% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (22% increase in shares outstanding). Market cap is less than US$100m (€44.1m market cap, or US$48.0m).
お知らせ • Mar 25Facephi Biometria, S.A. announced that it expects to receive funding from Hancom Inc.Facephi Biometria, S.A. announced that it has entered into an investment agreement with returning investor Hancom Inc. to issue common shares on March 25, 2024.
分析記事 • Dec 28Cautious Investors Not Rewarding Facephi Biometria, S.A.'s (BME:FACE) Performance CompletelyThere wouldn't be many who think Facephi Biometria, S.A.'s ( BME:FACE ) price-to-sales (or "P/S") ratio of 1.6x is...
New Risk • Nov 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.9% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Large one-off items impacting financial results. Shareholders have been diluted in the past year (14% increase in shares outstanding). Market cap is less than US$100m (€47.5m market cap, or US$51.7m).
分析記事 • Oct 04At €1.81, Is Facephi Biometria, S.A. (BME:FACE) Worth Looking At Closely?While Facephi Biometria, S.A. ( BME:FACE ) might not be the most widely known stock at the moment, it saw significant...
Valuation Update With 7 Day Price Move • Oct 03Investor sentiment deteriorates as stock falls 32%After last week's 32% share price decline to €1.81, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 25x in the Software industry in Europe. Total loss to shareholders of 68% over the past three years.
分析記事 • Dec 23Investors Will Want Facephi Biometria's (BME:FACE) Growth In ROCE To PersistIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Board Change • Nov 16Less than half of directors are independentThere are 6 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 6 new directors. 3 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Vice President of the Board Fernando Orteso De Travesedo is the most experienced director on the board, commencing their role in 2015. Independent Director Pablo Boranat was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • Nov 10First half 2022 earnings releasedFirst half 2022 results: Revenue: €9.72m (up 98% from 1H 2021). Net loss: €1.07m (loss narrowed 37% from 1H 2021). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 9.1% growth forecast for the Software industry in Europe.
分析記事 • May 20Would Facephi Biometria (BME:FACE) Be Better Off With Less Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Reported Earnings • May 01Full year 2021 earnings: Revenues miss analyst expectationsFull year 2021 results: Revenue: €15.3m (up 89% from FY 2020). Net loss: €553.9k (loss narrowed 67% from FY 2020). Revenue missed analyst estimates by 25%.
Board Change • Apr 27Less than half of directors are independentThere are 7 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 7 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Fernando Orteso De Travesedo is the most experienced director on the board, commencing their role in 2015. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
分析記事 • Jan 01What Does Facephi Biometria, S.A.'s (BME:FACE) Share Price Indicate?Facephi Biometria, S.A. ( BME:FACE ), might not be a large cap stock, but it saw significant share price movement...
Reported Earnings • May 24Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: €8.13m (down 7.5% from FY 2019). Net loss: €1.68m (down 231% from profit in FY 2019).
分析記事 • Feb 14When Should You Buy Facephi Biometria, S.A. (BME:FACE)?Facephi Biometria, S.A. ( BME:FACE ), might not be a large cap stock, but it received a lot of attention from a...
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to €3.90, the stock is trading at a trailing P/E ratio of 52x, down from the previous P/E ratio of 64.7x. This compares to an average P/E of 40x in the Software industry in Europe. Total returns to shareholders over the past three years are 282%.
Is New 90 Day High Low • Feb 01New 90-day low: €3.90The company is down 31% from its price of €5.68 on 03 November 2020. The Spanish market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 14% over the same period.
分析記事 • Jan 25We Wouldn't Rely On Facephi Biometria's (BME:FACE) Statutory Earnings As A GuideBroadly speaking, profitable businesses are less risky than unprofitable ones. Having said that, sometimes statutory...
Is New 90 Day High Low • Jan 15New 90-day low: €4.95The company is down 20% from its price of €6.20 on 16 October 2020. The Spanish market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 9.0% over the same period.
Is New 90 Day High Low • Dec 30New 90-day low: €5.04The company is down 13% from its price of €5.80 on 01 October 2020. The Spanish market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 7.0% over the same period.
分析記事 • Dec 30The Facephi Biometria (BME:FACE) Share Price Is Up 979% And Shareholders Are DelightedWhile Facephi Biometria, S.A. ( BME:FACE ) shareholders are probably generally happy, the stock hasn't had particularly...
Is New 90 Day High Low • Dec 10New 90-day low: €5.38The company is down 13% from its price of €6.18 on 10 September 2020. The Spanish market is up 13% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Software industry, which is down 14% over the same period.
Is New 90 Day High Low • Nov 02New 90-day low: €5.44The company is down 6.0% from its price of €5.80 on 04 August 2020. The Spanish market is also down 6.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Software industry, which is down 20% over the same period.